Kyverna Therapeutics, Inc. (KYTX) SEC filings
KYTX SEC filings moved a median of -2.73% by the close. KYTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KYTX overview →
62 measured KYTX SEC filing events.
Where these KYTX SEC filings landedvs 60 measured KYTX SEC filing reactions
| Middle 50% of KYTX SEC filing reactions | -7.79% to +0.74% |
|---|---|
| Median reaction (to close) | -2.73% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 KYTX SEC filing events with a measured close landed between -7.79% and +0.74%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Kyverna Therapeutics, For: Sep 24 | SEC filing · Form 8-K | +0.13% | -10.38% | |
| Form 10-Q Kyverna Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.51% | +1.64% | |
| Form 8-K Kyverna Therapeutics, For: Aug 11 | SEC filing · Form 8-K | +0.51% | +1.64% | |
| Form 8-K Kyverna Therapeutics, For: Jul 23 | SEC filing · Form 8-K | +3.28% | +6.17% | |
| Form 8-K Kyverna Therapeutics, For: Jul 08 | SEC filing · Form 8-K | -0.30% | -1.70% | |
| Form 8-K Kyverna Therapeutics, For: May 27 | SEC filing · Form 8-K | +0.77% | -0.26% | |
| Form 8-K Kyverna Therapeutics, For: May 14 | SEC filing · Form 8-K | -1.28% | -8.56% | |
| Form 10-Q Kyverna Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +5.13% | +4.76% | |
| Form 8-K Kyverna Therapeutics, For: May 12 | SEC filing · Form 8-K | +5.13% | +4.76% | |
| Form 8-K Kyverna Therapeutics, For: May 04 | SEC filing · Form 8-K | +1.59% | +2.16% | |
| Form 8-K Kyverna Therapeutics, For: Apr 21 | SEC filing · Form 8-K | -11.73% | -7.67% | |
| Form 8-K Kyverna Therapeutics, For: Apr 22 | SEC filing · Form 8-K | -11.73% | -7.67% | |
| Form 8-K Kyverna Therapeutics, For: Apr 20 | SEC filing · Form 8-K | +2.05% | +9.76% | |
| Form ARS Kyverna Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.57% | -2.60% | |
| Form DEF 14A Kyverna Therapeutics, For: May 27 | SEC filing · Form DEF | -0.57% | -2.60% | |
| Form DEFA14A Kyverna Therapeutics, | SEC filing · Form DEFA14A | -0.57% | -2.60% | |
| Form EFFECT Kyverna Therapeutics, | SEC filing · Form EFFECT | +1.13% | +1.13% | |
| Form 10-K Kyverna Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.50% | -2.86% | |
| Form 8-K Kyverna Therapeutics, For: Mar 26 | SEC filing · Form 8-K | -0.50% | -2.86% | |
| Form S-3 Kyverna Therapeutics, | SEC filing · Form S-3 | -0.50% | -2.86% | |
| Form S-8 Kyverna Therapeutics, | SEC filing · Form S-8 | -0.50% | -2.86% | |
| Form 8-K Kyverna Therapeutics, For: Feb 24 | SEC filing · Form 8-K | +1.08% | +0.63% | |
| Form 8-K Kyverna Therapeutics, For: Jan 29 | SEC filing · Form 8-K | +1.68% | -0.36% | |
| Form 8-K Kyverna Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -3.61% | -0.84% | |
| Form 8-K Kyverna Therapeutics, For: Dec 17 | SEC filing · Form 8-K | -1.98% | -1.13% | |
| Form 8-K Kyverna Therapeutics, For: Dec 15 | SEC filing · Form 8-K | -2.54% | -11.31% | |
| Form 10-Q Kyverna Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.11% | — | |
| Form 8-K Kyverna Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -1.11% | — | |
| Form 8-K Kyverna Therapeutics, For: Nov 02 | SEC filing · Form 8-K | -1.14% | -2.41% | |
| Form 8-K Kyverna Therapeutics, For: Oct 29 | SEC filing · Form 8-K | -7.75% | -10.38% | |
| Form 8-K Kyverna Therapeutics, For: Sep 19 | SEC filing · Form 8-K | -2.27% | -4.69% | |
| Form 10-Q Kyverna Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.32% | +14.14% | |
| Form 8-K Kyverna Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -1.32% | +14.14% | |
| Form 8-K Kyverna Therapeutics, For: Jun 30 | SEC filing · Form 8-K | -0.63% | -4.06% | |
| Form 8-K Kyverna Therapeutics, For: May 29 | SEC filing · Form 8-K | +0.07% | +1.42% | |
| Form 10-Q Kyverna Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.86% | -7.33% | |
| Form 8-K Kyverna Therapeutics, For: May 13 | SEC filing · Form 8-K | +0.86% | -7.33% | |
| Form EFFECT Kyverna Therapeutics, | SEC filing · Form EFFECT | +0.00% | -7.58% | |
| Form ARS Kyverna Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | -10.18% | |
| Form DEF 14A Kyverna Therapeutics, For: May 29 | SEC filing · Form DEF | +0.00% | -10.18% | |
| Form DEFA14A Kyverna Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -10.18% | |
| Form 10-K Kyverna Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.13% | -14.89% | |
| Form 8-K Kyverna Therapeutics, For: Mar 27 | SEC filing · Form 8-K | +2.13% | -14.89% | |
| Form S-3 Kyverna Therapeutics, | SEC filing · Form S-3 | +2.13% | -14.89% | |
| Form S-8 Kyverna Therapeutics, | SEC filing · Form S-8 | +2.13% | -14.89% | |
| Form 8-K Kyverna Therapeutics, For: Jan 21 | SEC filing · Form 8-K | +1.05% | -1.50% | |
| Form 8-K Kyverna Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -1.44% | -5.46% | |
| Form 8-K Kyverna Therapeutics, For: Nov 26 | SEC filing · Form 8-K | +2.87% | +11.27% | |
| Form S-8 Kyverna Therapeutics, | SEC filing · Form S-8 | +2.87% | +11.27% | |
| Form 10-Q Kyverna Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.77% | -8.22% | |
| Form 8-K Kyverna Therapeutics, For: Nov 08 | SEC filing · Form 8-K | +0.77% | -8.22% | |
| Form 8-K Kyverna Therapeutics, For: Oct 20 | SEC filing · Form 8-K | -0.44% | -8.13% | |
| Form 8-K Kyverna Therapeutics, For: Sep 13 | SEC filing · Form 8-K | -1.83% | -2.96% | |
| Form 10-Q Kyverna Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.29% | +0.57% | |
| Form 8-K Kyverna Therapeutics, For: Aug 12 | SEC filing · Form 8-K | +0.29% | +0.57% | |
| Form 8-K Kyverna Therapeutics, For: Jul 15 | SEC filing · Form 8-K | +1.46% | +1.10% | |
| Form 8-K Kyverna Therapeutics, For: Jun 14 | SEC filing · Form 8-K | -19.76% | -32.98% | |
| Form 10-Q Kyverna Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +4.35% | +0.13% | |
| Form 8-K Kyverna Therapeutics, For: May 14 | SEC filing · Form 8-K | +4.35% | +0.13% | |
| Form 10-K Kyverna Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.71% | -3.02% | |
| Form 8-K Kyverna Therapeutics, For: Mar 26 | SEC filing · Form 8-K | -1.71% | -3.02% | |
| Form SEC STAFF LETTER Kyverna Therapeutics, | SEC filing · Form SEC | -0.92% | +1.08% |
Keep exploring
More KYTX: earnings → · analyst actions → · KYTX overview →